Abstract
BackgroundCheckpoint inhibitor-induced hepatitis (CPI-hepatitis) is an emerging problem with the widening use of CPIs in cancer immunotherapy. Here, we developed a mouse model to characterize the mechanism of CPI-hepatitis and...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have